Allscripts-Misys Healthcare Solutions, which has a major presence in the Triangle, and its rival Eclipsys are combining in a $1.35 billion all-stock deal, the companies announced early Wednesday.
CHICAGO--(BUSINESS WIRE)--Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) (Allscripts) announced its financial results for the three and six months ended June 30, 2021. Bookings (1) were $180 ...
Allscripts reported revenue lower than Wall Street expectations in the third quarter of $402.1 million, down almost 10% year over year in results released Thursday amid continued pandemic challenges ...
Allscripts Healthcare Solutions, Inc. MDRX is well-poised for growth in the coming quarters, backed by its strategic alliances over the past few months. A robust second-quarter 2022 performance and ...
LONDON/NEW YORK, June 9 (Reuters) - U.S. healthcare IT company Allscripts plans to buy rival Eclipsys in a $1.3 billion all-stock deal to capitalize on a huge influx of U.S. government funding for ...
EHR vendor Allscripts and NantHealth, the digital health wing of Dr. Patrick Soon-Shiong's NantWorks portfolio of companies, have announced a major cross investment, with Allscripts paying $200 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results